Loading…
Estrogen directly modulates circadian rhythms of PER2 expression in the uterus
Department of Biology, University of Virginia, Charlottesville, Virginia Submitted 24 April 2008 ; accepted in final form 24 August 2008 Fluctuations in circulating estrogen and progesterone levels associated with the estrous cycle alter circadian rhythms of physiology and behavior in female rodents...
Saved in:
Published in: | American journal of physiology: endocrinology and metabolism 2008-11, Vol.295 (5), p.E1025-E1031 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Department of Biology, University of Virginia, Charlottesville, Virginia
Submitted 24 April 2008
; accepted in final form 24 August 2008
Fluctuations in circulating estrogen and progesterone levels associated with the estrous cycle alter circadian rhythms of physiology and behavior in female rodents. Endogenously applied estrogen shortens the period of the locomotor activity rhythm in rodents. We recently found that estrogen implants affect Period ( Per ) gene expression in the suprachiasmatic nucleus (SCN; central clock) and uterus of rats in vivo. To explore whether estrogen directly influences the circadian clock in the SCN and/or tissues of the reproductive system, we examined the effects of 17β-estradiol (E 2 ) on PER2::LUCIFERASE (PER2::LUC) expression in tissue explant cultures from ovariectomized PER2::LUC knockin mice. E 2 applied to explanted cultures shortened the period of rhythmic PER2::LUC expression in the uterus but did not change the period of PER2::LUC expression in the SCN. Raloxifene, a selective estrogen receptor modulator and known E 2 antagonist in uterine tissues, attenuated the effect of E 2 on the period of the PER2::LUC rhythm in the uterus. These data indicate that estrogen directly affects the timing of the molecular clock in the uterus via an estrogen receptor-mediated response.
ovarian steroid hormone; period; PER2::LUCIFERASE; raloxifene; suprachiasmatic nucleus
Address for reprint requests and other correspondence: T. J. Nakamura, Dept. of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience, Univ. of California Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90024-1759 (e-mail: tnakamura{at}mednet.ucla.edu ) |
---|---|
ISSN: | 0193-1849 1522-1555 |
DOI: | 10.1152/ajpendo.90392.2008 |